Evaluation of a Clinical Decision Support System for Fungal Infections
NCT05656157 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 278
Last updated 2024-04-15
Summary
Invasive fungal infections are serious and frequent diseases in our hospitals, especially in intensive care units. In accordance with the institutional recommendations, it is necessary to have a clinical decision support system to support the clinicians in a rapid and optimal prescription of antifungals for invasive fungal diseases. This clinical decision support system will benefit patients but also clinicians who will gain in medical efficiency. It will also have an ethical dimension since it will guarantee optimal antifungal treatments for all patients. The purpose of the research is to define the percentage of concordance between the medical prescription and the recommendation of the clinical decision support system.
Conditions
- Invasive Fungal Infections
Interventions
- DEVICE
-
Medical device
Clinical decision support system
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Principal Investigators
-
Anne-Lise Bienvenu, PharmD, PhD · Hospices Civils de Lyon
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-01
- Primary Completion
- 2023-06-01
- Completion
- 2023-11-30
Countries
- France
Study Locations
More Related Trials
-
Systemic Fungal Infections in ICU Patients
NCT03292224 ·Status: UNKNOWN
-
Immunomonitoring of Mold Invasive Infections
NCT06285188 ·Status: RECRUITING
-
Empirical Antifungal Treatment in ICUS
NCT01773876 ·Status: COMPLETED ·Phase: PHASE3
-
Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients
NCT01260974 ·Status: UNKNOWN ·Phase: PHASE2
-
Echinocandins Versus Azoles for Candidemia Treatment
NCT03799172 ·Status: COMPLETED
-
Invasive Fungal Infections Surveillance Initiative
NCT00177944 ·Status: COMPLETED
-
Survey on the Current Status of IFD Diagnosis and Treatment by Intensive Care Physicians in Sichuan Province (IFS)
NCT06346951 ·Status: NOT_YET_RECRUITING
-
Clinical Impact of Fungal Domestic Environmental Exposure on COPD Patients
NCT02318524 ·Status: COMPLETED
-
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
NCT00445952 ·Status: COMPLETED
-
Pharmacokinetics of Micafungin in Patients of Intensive Care Units
NCT02164890 ·Status: COMPLETED ·Phase: PHASE4
-
Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients
NCT06498310 ·Status: RECRUITING
-
Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)
NCT00686621 ·Status: APPROVED_FOR_MARKETING
-
Markers of Infection and Resistance in Invasive Fusariosis
NCT04937751 ·Status: RECRUITING
-
Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients
NCT04157465 ·Status: COMPLETED ·Phase: NA
-
Fungal Infection Susceptibility
NCT00001352 ·Status: RECRUITING
-
An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections
NCT01823289 ·Status: COMPLETED ·Phase: PHASE4
-
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis
NCT01916057 ·Status: COMPLETED ·Phase: NA
-
Factors on Therapeutic Drug Monitoring and Safety of Voriconazole in Critically Ill Elderly Patients
NCT06137690 ·Status: RECRUITING
-
Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients
NCT03067350 ·Status: COMPLETED
-
Beta-Glucan Driven vs. Empirical Antifungal Therapy in Critically Ill Patients
NCT03117439 ·Status: COMPLETED ·Phase: NA
-
Screening Anti-Fungal Exposure in Intensive Care Units
NCT03136926 ·Status: UNKNOWN
-
Biomarkers for Invasive Mucormycosis
NCT05406037 ·Status: RECRUITING
-
Studies of Disorders With Increased Susceptibility to Fungal Infections
NCT01222741 ·Status: RECRUITING
-
Revision of Antifungal Strategies Definitions for Invasive Fungal Infections in Hematological Malignancies
NCT04024995 ·Status: COMPLETED
-
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
NCT02734862 ·Status: COMPLETED ·Phase: PHASE2